ru-66647 has been researched along with Scrub-Typhus* in 2 studies
1 trial(s) available for ru-66647 and Scrub-Typhus
Article | Year |
---|---|
Controlled trial of a 5-day course of telithromycin versus doxycycline for treatment of mild to moderate scrub typhus.
New antibiotics are required to have the antibacterial activity against doxycycline-resistant Orientia tsutsugamushi. An in vitro sensitivity study showed that telithromycin was more effective than erythromycin for Rickettsia, Bartonella, and Coxiella burnetii. In this prospective, open-label, randomized trial, we enrolled patients with mild-to-moderate scrub typhus. We compared the efficacy and safety of a 5-day telithromycin therapy with those of a 5-day doxycycline therapy at Chosun University Hospital or one of its two community-based affiliated hospitals (Jangheung Hospital and Cheomdan Hospital), which are all located in southwestern Korea, between September and December 2005. A total of 92 patients were randomly assigned to either the telithromycin group (n = 47) or the doxycycline group (n = 45). After the treatment, fever control time was 20.45 +/- 12.9 h in the telithromycin group and 22.60 +/- 21.44 h in the doxycycline group (P > 0.05). After the treatment, the cure rate was 100% in the telithromycin group and 97.8% in the doxycycline group (P > 0.05). Furthermore, there were no significant differences in time elapsed until such symptoms as headache, myalgia, and rash disappeared. No serious adverse events or death were noted following the treatment in both groups. There were no significant differences in adverse events. In conclusion, the efficacy and safety of a 5-day once-a-day regimen of 800 mg telithromycin were equivalent to those of a 5-day twice-a-day regimen of 100 mg doxycycline in patients with mild-to-moderate scrub typhus. Telithromycin could be considered a promising new antibacterial agent for patients with scrub typhus. Topics: Adult; Aged; Anti-Bacterial Agents; Doxycycline; Female; Humans; Ketolides; Male; Middle Aged; Scrub Typhus; Treatment Outcome | 2007 |
1 other study(ies) available for ru-66647 and Scrub-Typhus
Article | Year |
---|---|
Differences in clinical features according to Boryoung and Karp genotypes of Orientia tsutsugamushi.
Scrub typhus is an infectious disease caused by Orientia tsutsugamushi. The differences in virulence of O. tsutsugamushi prototypes in humans are still unknown. We investigated whether there are any differences in the clinical features of the Boryoung and Karp genotypes.. Patients infected with O. tsutsugamushi, as Boryoung and Karp clusters, who had visited 6 different hospitals in southwestern Korea were prospectively compared for clinical features, complications, laboratory parameters, and treatment responses. Infected patients in the Boryoung cluster had significantly more generalized weakness, eschars, skin rashes, conjunctival injection, high albumin levels, and greater ESR and fibrinogen levels compared to the Karp cluster. The treatment response to current antibiotics was significantly slower in the Karp cluster as compared to the Boryoung cluster.. The frequency of occurrence of eschars and rashes may depend on the genotype of O. tsutsugamushi. Topics: Adult; Aged; Anti-Bacterial Agents; Doxycycline; Female; Genotype; Humans; Ketolides; Male; Middle Aged; Orientia tsutsugamushi; Prospective Studies; Republic of Korea; Rifampin; Scrub Typhus; Serotyping; Species Specificity; Treatment Outcome | 2011 |